Clinical Trials Directory

Trials / Completed

CompletedNCT05418595

Ultrasonographic Evaluation of Ovarian Stromal Vascularity in Women With Polycystic Ovary Syndrome (PCOS)

Ultrasonographic Evaluation of Ovarian Stroma in PCOS Women

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Usak State Hospital · Academic / Other
Sex
Female
Age
18 Years – 38 Years
Healthy volunteers
Accepted

Summary

The most common endocrine condition in reproductive women is polycystic ovary syndrome. It has a prevalence of 5-10%. According to the Rotterdam criteria, oligo/anovulation, clinic or biochemical hyperandrogenism, PCOS morphology in ultrasonography, and the presence of these two criteria are required for diagnosis. The echogenicity of the ovarian stroma, vascularity, ovarian size, cystic pattern density, and subcortical organization of cysts are all significant considerations in ultrasonographic evaluation.

Detailed description

Retrospective archive study. In the years 2018-2019, the ultrasonographic archives of PCOS women will be analyzed retrospectively in the Radiology department of Usak Education and Research Hospital. Ultrasonographic (Two-dimensional ultrasonography , conventional and other doppler) measurements of ovaries will be assessed in ultrasonographic data. Patient's data ( Menstrual cycle, androgenic findings, age, BMI etc..) will be obtained on the hospital records, PCOS patient's phenotype will be evaluated according to National Institutes Health (NIH) recommendations. The ovarian ultrasonographic findings of PCOS women will be compared. This study approved by Usak University Medical Faculty Ethical Committee April,06,2022. The Ethical Committee decision number is 57-57-04.

Conditions

Interventions

TypeNameDescription
OTHER

Timeline

Start date
2022-06-13
Primary completion
2022-09-04
Completion
2022-09-04
First posted
2022-06-14
Last updated
2022-09-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05418595. Inclusion in this directory is not an endorsement.